Boosting cancer screenings in high-risk groups
Peer-Reviewed Publication
This month, we're turning our attention to Breast Cancer Awareness Month, a time dedicated to increasing awareness, supporting early detection, and highlighting the ongoing research shaping the future of breast cancer treatment and prevention.
Updates every hour. Last Updated: 20-Oct-2026 16:16 ET (20-Oct-2026 20:16 GMT/UTC)
Jefferson researchers work on prompting women who are at risk for lung cancer to get mammograms.
Rockville, MD (21September, 2026) The AIM-HI Accelerator Fund today announces that Laura Esserman, M.D., MBA, Alfred A. de Lorimier Endowed Chair in General Surgery, Director of the University of California San Francisco (UCSF) Breast Care Center, and Professor of Surgery and Radiology at the University of California, San Francisco, is selected unanimously by the 2026 Blue Ribbon Selection Committee as the recipient of the 2026 AIM-HI Beacon Award for Women Leaders in Oncology, from a pool of outstanding global nominees.
New research is changing what we know about breast, lung, and prostate cancers. On Thursday, October 1, the Alliance for Clinical Trials in Oncology will host a public webinar highlighting key findings from Alliance and Alliance Foundation Trials (AFT) studies presented at the 2026 American Society for Clinical Oncology (ASCO) Annual Meeting.
A new AI-powered test, IICM+, may enhance recurrence risk prediction in HR+, HER2-negative breast cancer. Developed and independently validated in over 4,400 participants from the landmark TAILORx trial, IICM+ outperformed a widely used test. However, further validation is needed. By analyzing TAILORx tumor specimens and more than a decade of patient outcomes, this research extends the impact of this groundbreaking trial.
Sexual wellbeing can often be overlooked during a woman’s recovery from breast cancer with many continuing to experience significant sexual and intimacy challenges long after treatment ends.